Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This comparison highlights retirement index funds with the smallest fees, helping you choose cost-efficient options for a brighter retirement.
27,211 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
Independence Day grilling costs rise to a new peak for a 10-person cookout, underscoring how inflation is shaping hol...
Meta Platforms is catching the eye of value-focused investors. This guide breaks down why meta stock could most under...
IBM shares surged as a resurfaced media clip spotlighted the company’s leadership while federal backing for quantum r...
As the July 1, 2026 MiCA deadline nears, EU regulators prepare to enforce licensing across crypto firms. Early moves ...
A Knoxville hospital will be renamed in Dolly Parton’s honor as her philanthropy inspires new literacy efforts at hom...
The stock market often rides policy signals as much as earnings. This piece digs into two decision scenarios that cou...
As the AI boom strong powers data-center growth, memory stocks are slipping. Analysts point to cyclical supply dynami...
Stock splits don’t change a business’s fundamentals, but they can spark buying interest. Learn how to find an unbelie...
Could short squeeze coming for Plug Power stock be the catalyst investors have been waiting for? This article breaks ...
Two AI-focused names have pulled back recently, but their paths diverge. This guide breaks down why palantir sandisk ...